Multiple Sclerosis, Relapsing-Remitting - 31 Studies Found Completed : An Observational Study for the Assessment of Compliance and Persistence to Rebif® Therapy of Patients With Relapsing-remitting Multiple Sclerosis (MS) and Evaluation of Potential Factors Influencing These Parameters : Multiple Sclerosis, Relapsing-Remitting : 2010-04-26 Completed : A Study to Evaluate Rebif® New Formulation (Interferon-beta-1a) in Relapsing Remitting Multiple Sclerosis : Multiple Sclerosis, Relapsing-Remitting : 2007-02-26 : Drug: Rebif® New Formulation (IFN-beta-1a, RNF) Completed : A Phase II Study Comparing Low- and High-Dose Alemtuzumab and High-Dose Rebif® in Patients With Early, Active Relapsing-Remitting Multiple Sclerosis : Multiple Sclerosis, Relapsing-Remitting : 2002-12-19 : Biological: Interferon beta-1a Terminated : Minocycline as add-on to Interferon Beta-1a [IFN Beta-1a] (Rebif®) in Relapsing-Remitting Multiple Sclerosis [RRMS] : Multiple Sclerosis, Relapsing-Remitting : 2010-05-28 : Drug: Minocycline Participants Completed : A Study of Rebif® Compared With Avonex® in the Treatment of Relapsing-remitting Multiple Sclerosis (MS) : Multiple Sclerosis, Relapsing-Remitting : 2006-02-13 : Drug: Rebif® Rebif® Completed : Study to Assess Whether GSK239512 Can Remyelinate Lesions in Subjects With Relapsing Remitting Multiple Sclerosis : Multiple Sclerosis, Relapsing-Remitting : 2013-01-17 : Drug: GSK239512 White to almos Completed : Melatonin in Relapsing-Remitting Multiple Sclerosis Patients : Multiple Sclerosis, Relapsing-Remitting : 2011-01-18 : Drug: Melatonin 3mg oral, daily, one hour before sleep Enrolling by invitation : Pilot Trial of Domperidone in Relapsing-Remitting Multiple Sclerosis (RRMS) : Multiple Sclerosis, Relapsing-Remitting : 2015-07-02 : Drug: Domperidone Addition of Domperidone to current Disease Modifying Therapy. Completed : Study Assessing Cognition in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Treated With BG00012 : Multiple Sclerosis, Relapsing-Remitting : 2015-10-16 : Drug: dimethyl fumarate dimethyl fumarate administered as per the arm description Completed : Participants Preferences to Disease Modifying Agents in Relapsing Remitting Multiple Sclerosis Condition : Multiple Sclerosis, Relapsing-Remitting : 2015-11-04 Next >>>
